Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
PCNA Antibody (SPM350), DyLight 350, Novus Biologicals™

Mouse Monoclonal Antibody
Supplier: Novus Biologicals NBP234767UV
Description
PCNA Monoclonal specifically detects PCNA in Human, Mouse, Rat, Porcine, Chicken, Drosophila, Monkey, S. pombe, Yeast, Zebrafish samples. It is validated for Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin.Specifications
PCNA | |
Monoclonal | |
DyLight 350 | |
cyclin, DNA polymerase delta auxiliary protein, MGC8367, proliferating cell nuclear antigen | |
Mouse | |
36 kDa | |
0.1 mL | |
Autophagy, Base Excision Repair, Cell Cycle and Replication, Cellular Markers, Core ESC Like Genes, DNA Polymerases, DNA Repair, Stem Cell Markers | |
5111 | |
Human, Mouse, Rat, Pig, Chicken, Drosophila, Primate, Yeast, Zebrafish | |
Purified |
Western Blot, Flow Cytometry, ELISA, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin) | |
SPM350 | |
Western Blot, Flow Cytometry, ELISA, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen | |
PCNA | |
Rat PCNA/protein A fusion protein (Uniprot: P12004) | |
Protein A or G purified | |
RUO | |
Primary | |
Recognizes a non-histone protein of 36kDa, which is identified as proliferating cell nuclear antigen (PCNA). It is also known as cyclin or polymerase delta auxiliary protein. Elevated expression of PCNA/cyclin has been shown in the nucleus during late G1 phase immediately before the onset of DNA synthesis, becoming maximal during S-phase and declining during G2 and M phases. This monoclonal antibody is excellent for multiple applications. | |
Store at 4C in the dark. | |
IgG2a κ |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction